ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
Sobi snags FDA nod for rare disease drug Gamifant
fiercepharma
November 22, 2018Several months after scooping up global rights to emapalumab in a $452 million deal, Sobi has won?approval?for the drug to treat certain patients with?primary hemophagocytic lymphohistiocytosis.
Pharma Sources Insight January 2025
